RICHMOND, British Columbia--(BUSINESS WIRE)--BioCurex Inc. (OTCBB:BOCX) announced today that it has signed a collaboration agreement with the Blokhin Cancer Research Center in Moscow, Russia, for further development and evaluation of its RECAFTM technology.
